Building Resilience in the Pharmaceutical Supply Chain: Lessons from the Pandemic?
Kotter Inc.
OCTOBER 20, 2022
Both Anders and Chris have life-long careers in the Pharma industry, holding senior roles in both Big Pharma and smaller biotech companies. need to get raw materials from elsewhere because a supplier went out of business, process improvement, technology advancement, etc.), all these things are post-approval changes.
40 
Let's personalize your content